TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)
CUSIP: 89854M101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Voting Common Stock, par value $0.0001 per share
- Shares outstanding
- 52,382,313
- Total 13F shares
- 41,438,662
- Share change
- +7,144,001
- Total reported value
- $242,461,718
- Price per share
- $5.85
- Number of holders
- 78
- Value change
- +$40,505,361
- Number of buys
- 48
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 89854M101?
CUSIP 89854M101 identifies TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89854M101:
Top shareholders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
13F
|
Company |
10%
|
5,224,600
|
$41,483,324 | — | 31 Mar 2024 | |
| EcoR1 Capital, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
9.5%
|
5,000,000
|
$39,700,000 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
7.4%
|
3,900,000
|
$30,966,000 | — | 31 Mar 2024 | |
| BVF INC/IL |
13F
|
Company |
5.7%
|
2,989,474
|
$23,736,424 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.3%
|
2,784,792
|
$22,111,248 | — | 31 Mar 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
4%
|
2,087,139
|
$16,571,884 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
1,808,152
|
$14,356,727 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.2%
|
1,699,213
|
$13,491,751 | — | 31 Mar 2024 | |
| Christoph H. Westphal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,193,472
|
$10,898,266 | — | 20 Jul 2021 | |
| Deer Management Co. LLC |
13F
|
Company |
2.4%
|
1,245,504
|
$9,889,302 | — | 31 Mar 2024 | |
| Alphabet Inc. |
13F
|
Company |
2.1%
|
1,077,080
|
$8,552,015 | — | 31 Mar 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
2%
|
1,046,916
|
$8,312,513 | — | 31 Mar 2024 | |
| DC Funds, LP |
13F
|
Company |
1.2%
|
630,000
|
$5,002,200 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.93%
|
488,415
|
$3,878,015 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.79%
|
413,779
|
$3,286,207 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.75%
|
392,115
|
$3,113,393 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.69%
|
362,484
|
$2,878,123 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.57%
|
297,902
|
$2,365,342 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
260,148
|
$2,065,575 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
223,894
|
$1,777,719 | — | 31 Mar 2024 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.41%
|
212,200
|
$1,684,868 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.38%
|
200,000
|
$1,588,000 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.36%
|
191,171
|
$1,517,898 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.29%
|
153,133
|
$1,215,876 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.27%
|
143,536
|
$1,139,676 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.26%
|
135,000
|
$1,071,900 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.22%
|
116,921
|
$928,353 | — | 31 Mar 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.19%
|
101,400
|
$805,116 | — | 31 Mar 2024 | |
| NewEdge Wealth, LLC |
13F
|
Company |
0.17%
|
91,463
|
$791,155 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.15%
|
77,339
|
$614,072 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
76,960
|
$611,062 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.13%
|
67,013
|
$532,083 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
63,300
|
$502,602 | — | 31 Mar 2024 | |
| Timothy J. Barberich |
3/4/5
|
Director |
—
mixed-class rows
|
135,286
mixed-class rows
|
$498,271 | — | 18 Dec 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.1%
|
52,478
|
$416,675 | — | 31 Mar 2024 | |
| Marathon Trading Investment Management LLC |
13F
|
Company |
0.1%
|
51,000
|
$404,940 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
47,000
|
$373,000 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.08%
|
44,308
|
$351,806 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.08%
|
41,942
|
$333,019 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.07%
|
37,747
|
$299,711 | — | 31 Mar 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.07%
|
35,661
|
$283,000 | — | 31 Mar 2024 | |
| DC Investments Management, LLC |
13F
|
Company |
0.07%
|
35,563
|
$282,370 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.07%
|
34,789
|
$276,000 | — | 31 Mar 2024 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.07%
|
34,578
|
$274,549 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
31,885
|
$253,167 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
30,179
|
$239,622 | — | 31 Mar 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.05%
|
24,446
|
$194,101 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
22,104
|
$175,506 | — | 31 Mar 2024 | |
| Pale Fire Capital SE |
13F
|
Company |
0.04%
|
21,573
|
$171,290 | — | 31 Mar 2024 | |
| LETKO, BROSSEAU & ASSOCIATES INC |
13F
|
Company |
0.04%
|
20,700
|
$164,358 | — | 31 Mar 2024 |
Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q2 2024
As of 30 Jun 2024,
TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,438,662 shares.
The largest 10 holders included
Lynx1 Capital Management LP, EcoR1 Capital, LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Propel Bio Management, LLC, Deer Management Co. LLC, and Alphabet Inc..
This page lists
78
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
65
Q2 2024 holders
78
Holder diff
13
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.